WuXi PharmaTech (Cayman) Inc. (ADR)  

(Public, NYSE:WX)   Watch this stock  
Find more results for WX
Dec 10 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 3.27B
P/E 39.02
Div/yield     -
EPS 1.18
Shares 568.02M
Beta     -
Inst. own 11%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 7.52% 16.63%
Operating margin 12.09% 15.38%
EBITD margin - 22.26%
Return on average assets 4.67% 10.53%
Return on average equity 6.93% 14.83%
Employees 9,082 -
CDP Score - -


288 Fute Zhong Road China (Shanghai) Pilot Free Trade Zone
+86-21-50461111 (Phone)
+86-21-50461000 (Fax)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


WuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.